The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
May. 17, 2022
Filed:
Jan. 25, 2016
Applicants:
Thrombosis Research Institute, London, GB;
Lord Kakkar, London, GB;
Inventors:
Vijay Kakkar, London, GB;
Xinjie Lu, London, GB;
Assignee:
THROMBOSIS RESEARCH INSTITUTE, London, GB;
Attorney:
Primary Examiner:
Int. Cl.
CPC ...
C07K 14/775 (2006.01); A61K 39/00 (2006.01); A61K 39/118 (2006.01); C07K 14/195 (2006.01); C07K 14/35 (2006.01); C07K 14/295 (2006.01); C07K 14/47 (2006.01); C07K 14/705 (2006.01);
U.S. Cl.
CPC ...
C07K 14/775 (2013.01); A61K 39/0005 (2013.01); A61K 39/0008 (2013.01); A61K 39/0012 (2013.01); A61K 39/118 (2013.01); C07K 14/195 (2013.01); C07K 14/295 (2013.01); C07K 14/35 (2013.01); C07K 14/47 (2013.01); C07K 14/70596 (2013.01); A61K 2039/58 (2013.01); A61K 2039/6081 (2013.01); A61K 2039/64 (2013.01);
Abstract
The invention relates to multiple epitope constructs, immunogenic and vaccine compositions comprising recombinant molecules presenting inserted multiple and different epitopes from a variety of antigens. The antigenic determinants being associated with different pathways leading to atherosclerosis. In particular, the invention relates to such compositions for eliciting an immune response against antigens and pathogens involved in the development of atherosclerosis the invention includes intermethods of treating and/or preventing the disease and recombinant protein products.